Edison Provides Update on Brighter: Poised for Revenue Momentum

Brighter AB [publ), announced today that Edison provided an updated analysis report on the company. Here is a summary from the report: 

Brighter recently reported its results for the first quarter of 2021 and continues to be poised for revenue momentum at the end of the year. Actiste has market approval in Saudi Arabia, the United Arab Emirates (UAE) and Thailand, as well as a five-year distribution agreement in Qatar and five-year agreements in both Nigeria and Ghana. The entire analysis can be found here: (insert link)

For more information, please contact:

Investor Relations
ir@brighter.se

Certified Adviser

Brighter's Certified Adviser is Eminovo Fondkommission AB, +46 [0)8 - 684 211 10, odviser@eminovo.se, www.eminovo.se.

About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to provide smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.